Reuters logo
BRIEF-Spring Bank Pharmaceuticals provides update on sting platform
June 7, 2017 / 11:34 AM / 5 months ago

BRIEF-Spring Bank Pharmaceuticals provides update on sting platform

June 7 (Reuters) - Spring Bank Pharmaceuticals Inc

* Spring Bank provides update on its next-generation sting platform and announces publication of an abstract at ASCO related to its lead sting agonist candidate, SB 11285

* Spring Bank is advancing development of SB 11285 with plan to initiate its first clinical trial in 2018 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below